Valuation: Optigenex Inc.

Market Cap 19.94K 17.72K 16.42K 14.94K 28.2K 1.89M 28.65K 197K 77.41K 987K 74.82K 73.22K 3.15M P/E 2006 *
-
P/E 2007 -
Enterprise Value 8.95M 7.96M 7.38M 6.71M 12.67M 850M 12.87M 88.67M 34.77M 443M 33.6M 32.89M 1.41B EV / Sales 2006
20.5x
EV / Sales 2007 19.3x
Free-Float
21.27%
Yield 2006 *
-
Yield 2007 -
1 day+66.67%
1 week+166,566.67%
Current month+166,566.67%
1 month+166,566.67%
3 months+166,566.67%
6 months+166,566.67%
Current year+166,566.67%
1 week 0
Extreme 0.0003
0.5
1 month 0
Extreme 0.0003
0.5
Current year 0
Extreme 0.0003
0.5
1 year 0
Extreme 0.0002
0.5
3 years 0
Extreme 0.0002
0.5
5 years 0
Extreme 0.0002
1
10 years 0
Extreme 0
3
Manager TitleAgeSince
Chief Executive Officer 69 -
Change 5-day change 1-year change 3-year change Capi.($)
+66.67%+166,566.67%+1,140.69%-50.00% 35
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average +6.51%+3.25%+145.72%+50.49% 394.09B
Weighted average by Cap. +0.13%+3.83%+39.18%+71.44%

Financials

2006 2007
Net sales 301K 267K 248K 226K 426K 28.56M 432K 2.98M 1.17M 14.9M 1.13M 1.11M 47.51M 466K 414K 384K 349K 659K 44.22M 670K 4.61M 1.81M 23.08M 1.75M 1.71M 73.57M
Net income -7.36M -6.54M -6.06M -5.52M -10.41M -698M -10.57M -72.86M -28.57M -364M -27.61M -27.02M -1.16B -2.9M -2.58M -2.39M -2.17M -4.1M -275M -4.16M -28.7M -11.25M -144M -10.88M -10.64M -458M
Net Debt 6M 5.33M 4.94M 4.5M 8.49M 569M 8.62M 59.41M 23.29M 297M 22.51M 22.03M 947M 8.93M 7.94M 7.36M 6.7M 12.64M 848M 12.84M 88.48M 34.69M 442M 33.53M 32.82M 1.41B
Logo Optigenex Inc.
Optigenex Inc. is an applied sciences company. The Company is focused on providing solutions for healthy age management. Its ac-11 is the patented compound that helps the body to repair its own deoxyribonucleic acid (DNA). Its ac-11 is used in both dietary supplements and advanced cosmetics to repair skin damaged by overexposure to the sun, restore optimal cellular function, and promote healthy aging. The Company's technology helps the body’s natural ability to repair DNA; enhances the immune system by increasing the life cycle of white blood cells; repairs neural function damaged by overexposure to high decibel noise; helps to normalize the expression of NF-KB, thereby regulating the cellular response to systemic inflammation; maintains telomere length and integrity during the process of cellular mitosis, and increases production of natural collagen III.
Employees
1
Date Price Change Volume
26-10-16 US$0.000300 -.--% 900
  1. Stock Market
  2. Stocks
  3. OPGX Stock